297 results on '"Catalano, Onofrio"'
Search Results
2. Dual-energy CT applications on liver imaging: what radiologists and radiographers should know? A systematic review
3. Long-Term Outcomes of Tuberous Sclerosis Complex-Associated Non-functional Pancreatic Neuroendocrine Tumors: Should We Be More Conservative?
4. The synergistic effect of PET/MRI in whole-body oncologic imaging: an Expert Review
5. Diagnostic Anatomic Imaging for Neuroendocrine Neoplasms: Maximizing Strengths and Mitigating Weaknesses
6. Clinical Intricacies and Advances in Neuroendocrine Tumors: An Organ-Based Multidisciplinary Approach
7. Imaging of Neuroendocrine Neoplasms; Principles of Treatment Strategies. What Referring Clinicians Want to Know
8. State-of-the-Art Hybrid Imaging of Neuroendocrine Neoplasms
9. External validation of a machine learning based algorithm to differentiate hepatic mucinous cystic neoplasms from benign hepatic cysts
10. Development and Validation of a Noninvasive Model for the Detection of High-Risk Varices in Patients with Unresectable HCC
11. Simultaneous multislice diffusion-weighted imaging versus standard diffusion-weighted imaging in whole-body PET/MRI
12. HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Cancer
13. Predictors for spontaneous resolution of classical FUO in patients undergoing PET-CT
14. Abdominal Positron Emission Tomography/Magnetic Resonance Imaging
15. MRI restaging of rectal cancer: The RAC (Response–Anal canal–CRM) analysis joint consensus guidelines of the GRERCAR and GRECCAR groups
16. PET/MR enterography in inflammatory bowel disease: A review of applications and technical considerations
17. Immunotherapy-related renal toxicity causes reversible renal enlargement
18. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study
19. Quantitative imaging of uterine cancers with diffusion-weighted MRI and 18-fluorodeoxyglucose PET/CT
20. Clinical and pathological predictors for FDG-PET/CT avidity in patients with marginal zone lymphoma—a retrospective cohort study
21. Clinical Use of PET/MR in Oncology: An Update
22. PET/MR for evaluation of musculoskeletal malignancies
23. PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features
24. Detection and Characterization of Thrombosis in Humans Using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance
25. Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis
26. Conditional Survival in Resected Pancreatic Ductal Adenocarcinoma Patients Treated with Total Neoadjuvant Therapy
27. CT and MRI features differentiating mucinous cystic neoplasms of the liver from pathologically simple cysts
28. Pseudo-pneumatosis of the gastrointestinal tract: its incidence and the accuracy of a checklist supported by artificial intelligence (AI) techniques to reduce the misinterpretation of pneumatosis
29. Clinical impact of PET/MRI in oligometastatic colorectal cancer
30. Intraoperative Radiation Mitigates the Effect of Microscopically Positive Tumor Margins on Survival Among Pancreatic Adenocarcinoma Patients Treated with Neoadjuvant FOLFIRINOX and Chemoradiation
31. Impact of 18F-FDG PET/MR based tumor delineation in radiotherapy planning for cholangiocarcinoma
32. Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
33. Hepatectomy for Solitary Hepatocellular Carcinoma: Resection Margin Width Does Not Predict Survival
34. Impact of PET/MRI in the Treatment of Pancreatic Adenocarcinoma: a Retrospective Cohort Study
35. PET/MRI assessment of lung nodules in primary abdominal malignancies: sensitivity and outcome analysis
36. An international expert opinion statement on the utility of PET/MR for imaging of skeletal metastases
37. Positron Emission Tomography/Magnetic Resonance Imaging Versus the Standard of Care Imaging in the Diagnosis of Peritoneal Carcinomatosis
38. Improving staging of rectal cancer in the pelvis: the role of PET/MRI
39. Abdominal and pelvic 18F-FDG PET/MR: a review of current and emerging oncologic applications
40. Collagen type I PET/MRI enables evaluation of treatment response in pancreatic cancer in pre-clinical and first-in-human translational studies.
41. An Illustrated Review of the Recent 2019 World Health Organization Classification of Neuroendocrine Neoplasms: A Radiologic and Pathologic Correlation.
42. Comparison of acceptance of PET/MR enterography and ileocolonoscopy in patients with inflammatory bowel diseases
43. Hybrid imaging of the abdomen and pelvis
44. PET/MRI Radiomics in Rectal Cancer: a Pilot Study on the Correlation Between PET- and MRI-Derived Image Features with a Clinical Interpretation
45. Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma
46. Comparison between pelvic PSMA-PET/MR and whole-body PSMA-PET/CT for the initial evaluation of prostate cancer: a proof of concept study
47. The role of FDG PET/CT radiomics in the prediction of pathological response to neoadjuvant treatment in patients with esophageal cancer.
48. Publisher Correction to: PET/MRI and PET/CT Radiomics in Primary Cervical Cancer: A Pilot Study on the Correlation of Pelvic PET, MRI, and CT Derived Image Features
49. Clinical impact of PET/MR in treated colorectal cancer patients
50. Local and whole-body staging in patients with primary breast cancer: a comparison of one-step to two-step staging utilizing 18F-FDG-PET/MRI
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.